Your browser doesn't support javascript.
loading
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes.
Roy Chowdhury, Roshni; Vallania, Francesco; Yang, Qianting; Lopez Angel, Cesar Joel; Darboe, Fatoumatta; Penn-Nicholson, Adam; Rozot, Virginie; Nemes, Elisa; Malherbe, Stephanus T; Ronacher, Katharina; Walzl, Gerhard; Hanekom, Willem; Davis, Mark M; Winter, Jill; Chen, Xinchun; Scriba, Thomas J; Khatri, Purvesh; Chien, Yueh-Hsiu.
Afiliación
  • Roy Chowdhury R; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
  • Vallania F; Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA.
  • Yang Q; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.
  • Lopez Angel CJ; Division of Biomedical Informatics, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Darboe F; Shenzhen Key Laboratory of Infection and Immunity, Shenzhen Third People's Hospital, Shenzhen, China.
  • Penn-Nicholson A; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
  • Rozot V; Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA.
  • Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Malherbe ST; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Ronacher K; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Walzl G; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Hanekom W; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Davis MM; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Winter J; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Chen X; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Scriba TJ; Department of Science and Technology, National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Stellenbosch, South Africa.
  • Khatri P; Department of Science and Technology, National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Stellenbosch, South Africa.
  • Chien YH; South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Nature ; 560(7720): 644-648, 2018 08.
Article en En | MEDLINE | ID: mdl-30135583

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Células Asesinas Naturales / Linfocitos / Progresión de la Enfermedad Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Humans País/Región como asunto: Africa / Asia Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Células Asesinas Naturales / Linfocitos / Progresión de la Enfermedad Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Humans País/Región como asunto: Africa / Asia Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos